Company profile
Biovie Inc.
Pipeline2 assets
- BezisterimNE3107 / ERK; NF-κB; TNF-α / oral small molecule anti-inflammatory insulin sensitizer / neurology; neurodegenerative diseaseAlzheimer’s diseasePhase 2/3 conductedclinicalParkinson’s diseasePhase 2SUNRISE-PD last patient evaluation completed; topline targeted Q3 2026USLong COVID neurological symptomsPhase 2ADDRESS-LC enrollingUS
- BIV201BIV201 / continuous infusion formulation of terlipressin / liver diseaseascites due to liver cirrhosisPhase 3 planningclinical developmentUSrefractory ascitesPhase 2b completedclinical developmentUS